Document is current

Article History

Received: 24 September 2024

Accepted: 14 January 2025

First Online: 22 January 2025

Declarations

:

: This study was conducted after preparing the research protocol, obtaining an approval by the Shiba Palace Clinic Ethics Review Committee (approval no. 153969_rn-36564), and a registration to the University Hospital Medical Information Network (UMIN) Clinical Trial Registry (registration no. UMIN000053645; registration date, February 19, 2024). An opt-out for the study was not implemented because the personal patient and hospital information obtained from the database were anonymized and there was no correspondence table. This study complied with the applicable guidelines outlined in the Strengthening the Reporting of Observational Studies in Epidemiology statement [16] and in the REporting of studies Conducted using Observational Routinely-collected health Data statement [17].

: Not applicable.

: Y. K. received adviser fees and lecture fees from Otsuka Pharmaceutical Factory, Inc. K. M. received adviser fees from Otsuka Pharmaceutical Factory, Inc. N. H. and S. K. were employed by Otsuka Pharmaceutical Factory, Inc.